e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 73

Multiple sclerosis: molecular pathogenesis and therapeutic intervention

Imane Boutitah-Benyaich; Herena Eixarch; Javier Villacieros‐Álvarez; Arnau Hervera; Álvaro Cobo‐Calvo; Xavier Montalbán; Carmen Espejo · 2025 · Signal Transduction and Targeted Therapy

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Multiple sclerosis is a chronic immune-mediated disorder of the central nervous system characterized by demyelination, axonal loss, and neuroinflammation, culminating in progressive neurological disability. Despite significant advances in understanding its immunopathogenesis, current immunotherapies remain limited in their ability to halt disease progression, making multiple sclerosis incurable and highlighting the critical need for novel therapeutic strategies. Antigen-specific immunotherapy represents a groundbreaking approach that aims to restore immune tolerance to myelin-derived antigens

Abstract by Imane Boutitah-Benyaich; Herena Eixarch; Javier Villacieros‐Álvarez; Arnau Hervera; Álvaro Cobo‐Calvo; Xavier Montalbán; Carmen Espejo, Signal Transduction and Targeted Therapy (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41392-025-02415-4